The Effect of Bcr-Abl Protein Tyrosine Kinase on Maturation and Proliferation of Primitive Haematopoietic Cells

Molecular Medicine

Volumn 6, Issue 10, 2000, Pages 892-902

  Buckle, Anne Marie ^a   Mottram, Rachel ^a   Pierce, Andrew ^a   Lucas, Guy S ^b   Russell, Nigel ^c   Miyan, Jaleel A ^a   Whetton, Anthony D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Chronic Myeloid Leukemia (CML); Multiparameter Flow Cytometric Analysis; Primitive Haematopoietic Cells; Stem Cell Compartment; Stem Cells

Indexed keywords

BCR ABL PROTEIN; DNA BINDING PROTEIN; MILK PROTEIN; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL DIVISION; CHRONIC MYELOID LEUKEMIA; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

CELL DIVISION; DNA-BINDING PROTEINS; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; MILK PROTEINS; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

MLCS; MLOWN;

EID: 0034296554     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401826     Document Type: Article

References (50)

1. J. Konopka S. Watanabe O. Witte An alteration of the human C-Abl protein in K562 leukemia-cells unmasks associated tyrosine kinase-activity Cell 1984 37 1035 1042 10.1016/0092-8674(84)90438-0 1:CAS:528:DyaL2cXltVKjs74%3D 6204766
2. T. Lugo A. Pendergast A. Muller O. Witte tyrosine kinase-activity and transformation potency of Bcr-Abl oncogene products Science 1990 247 1079 1082 10.1126/science.2408149 1:CAS:528:DyaK3cXhslensbg%3D 2408149
3. G. Daley R. Vanetten D. Baltimore induction of chronic myelogenous leukemia in mice by the P210 Bcr/Abl gene of the Philadelphia-chromosome Science 1990 247 824 830 10.1126/science.2406902 1:CAS:528:DyaK3cXhsFaqs7c%3D 2406902
4. A. Elefanty I. Hariharan S. Cory Bcr-Abl, the hallmark of chronic myeloid-leukemia in man, induces multiple hematopoietic neoplasms in mice EMBO J. 1990 9 1069 1078 1691092 551781 1:CAS:528:DyaK3cXktVeru7g%3D 10.1002/j.1460-2075.1990.tb08212.x
5. M. Kelliher J. McLoughlin O. Witte N. Rosenberg induction of a chronic myelogenous leukemia-like syndrome in mice with V-Abl and Bcr/Abl Proc. Nat. Acad. Sci. U.S.A. 1990 87 6649 6653 10.1073/pnas.87.17.6649 1:CAS:528:DyaK3cXls12lt7o%3D
6. M. Gishizky J. Johnsonwhite O. Witte efficient transplantation of Bcr-Abl-induced chronic myelogenous leukemia-like syndrome in mice Proc. Nat. Acad. Sci. USA 1993 90 3755 3759 10.1073/pnas.90.8.3755 1:CAS:528:DyaK3sXkvFams70%3D 8475126
7. X.W. Zhang R.B. Ren Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia Blood 1998 92 3829 3840 9808576 1:CAS:528:DyaK1cXnsVKlt70%3D
8. I. Lewis L. McDiarmid L. Samels L. To T. Hughes establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34(+) cells Blood 1998 91 630 640 9427719 1:CAS:528:DyaK1cXjsVWitw%3D%3D
9. N. Carlesso J. Griffin B. Druker use of a temperature-sensitive mutant to define the biological effects of the P210(Bcr-Abl) tyrosine kinase on proliferation of a factor-dependent murine myeloid cell-line Oncogene 1994 9 149 156 8302574 1:CAS:528:DyaK2cXhtlSqsbk%3D
10. J. Kabarowski P. Allen L. Wiedemann A temperature-sensitive P210 Bcr-Abl mutant defines the primary consequences of Bcr-Abl tyrosine kinase expression in growth-factor dependent cells EMBO J. 1994 13 5887 5895 7813429 395564 1:STN:280:DyaK2M7ht1Oquw%3D%3D 10.1002/j.1460-2075.1994.tb06934.x
11. G. Daley D. Baltimore Transformation of an interleukin-3-dependent hematopoietic-cell line by the chronic myelogenous leukemia-specific p210 Bcr/Abl protein Proc. Nat. Acad. Sci. U.S.A. 1988 85 9312 9316 10.1073/pnas.85.23.9312 1:CAS:528:DyaL1MXlsFWmsA%3D%3D
12. I.K. Hariharan J.M. Adams S. Cory Bcr-Abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia Oncogene Res. 1988 3 387 399 3147434 1:STN:280:DyaL1M7ksVGlsg%3D%3D
13. P. Laneuville G. Sun M. Timm M. Vekemans Clonal evolution in a myeloid cell-line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210 Bcr/Abl Blood 1992 80 1788 1797 1327283 1:CAS:528:DyaK3sXitVWitQ%3D%3D
14. A. Pierce P.J. Owen-Lynch E. Spooncer T.M. Dexter A.D. Whetton p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia Oncogene 1998 17 667 672 10.1038/sj.onc.1201969 1:CAS:528:DyaK1cXlsV2ns7w%3D 9704934
15. G. Daley Y. Ben Neriah Implicating the Bcr/Abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia Adv. Cancer Res. 1991 57 151 184 10.1016/S0065-230X(08)60998-7 1:CAS:528:DyaK38Xls1eqsQ%3D%3D 1950703
16. M. Gishizky O. Witte Initiation of deregulated growth of multipotent progenitor cells by Bcr-Abl in vitro Science 1992 25 836 839 10.1126/science.1375394
17. J. McLaughlin E. Chianese O. Witte In vitro transformation of immature hematopoietic-cells by the p210 Bcr Abl oncogene product of the Philadelphia-chromosome Proc. Nat. Acad. Sci. U.S.A. 1987 84 6558 6562 10.1073/pnas.84.18.6558 1:CAS:528:DyaL2sXmtFGmtLc%3D
18. P. Scherle K. Dorshkind O. Witte Clonal lymphoid progenitor-cell lines expressing the Bcr/Abl oncogene retain full differentiative function Proc. Nat. Acad. Sci. U.S.A. 1990 87 1908 1912 10.1073/pnas.87.5.1908 1:CAS:528:DyaK3cXhslKrur4%3D
19. J. Young O. Witte Selective transformation of primitive lymphoid-cells by the Bcr Abl oncogene expressed in long-term lymphoid or myeloid cultures Mol. Cell. Biol. 1988 8 4079 4087 10.1128/MCB.8.10.4079 1:CAS:528:DyaL1cXlvVCrtL0%3D 3263566 365477
20. K. Nishii J. Kabarowski D. Gibbons et al. ts Bcr-Abl kinase activation confers increased resistance to genotoxic damage via cell cycle block Oncogene 1996 13 2225 2234 8950990 1:CAS:528:DyaK28XnsFaht7g%3D
21. X.Y. Jiang A. Lopez T. Holyoake A. Eaves C. Eaves Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia Proc. Nat. Acad. Sci. U.S.A. 1999 96 12804 12809 10.1073/pnas.96.22.12804 1:CAS:528:DyaK1MXnt1yqtro%3D
22. V. Mauer-Satta A. Petzer A. Eaves C. Eaves Bcr-Abl expression in different subpopulations of functionally characterized Ph(+) CD34(+) cells from patients with chronic myeloid leukemia Blood 1996 88 1796 1804
23. D. Vandenberg M. Wessman L. Murray et al. Leukemic burden in subpopulations of CD34(+) cells isolated from the mobilized peripheral blood of α-interferon-resistant or intolerant patients with chronic myeloid leukemia Blood 1996 87 4348 4357 1:CAS:528:DyaK28XivFGhuro%3D
24. F.H. Grand A. Chase S. Iqbal et al. Two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia Genes Chromo. Cancer 1998 23 109 115 10.1002/(SICI)1098-2264(199810)23:2<109::AID-GCC3>3.0.CO;2-6 1:CAS:528:DyaK1cXlvFyht74%3D
25. G.W. Dewald W.A. Wyatt A.L. Juneau et al. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia Blood 1998 91 3357 3365 9558393 1:CAS:528:DyaK1cXislCns7k%3D
26. I. Bertoncello G. Hodgson T. Bradley Multiparameter analysis of transplantable hematopoietic stem-cells. The separation and enrichment of stem-cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence Exp. Hematology 1985 13 999 1006 1:STN:280:DyaL28%2FjtVGksw%3D%3D
27. G. Spangrude G. Johnson Resting and activated subsets of mouse multipotent hematopoietic stem-cells Proc. Nat. Acad. Sci. U.S.A. 1990 87 7433 7437 10.1073/pnas.87.19.7433 1:STN:280:DyaK3M%2FhslGhsg%3D%3D
28. C. Li G. Johnson Murine hematopoietic stem and progenitor cells. Enrichment and biologic characterization Blood 1995 85 1472 1479 7534130 1:CAS:528:DyaK2MXktlOgtLY%3D
29. T. Leemhuis M.C. Yoder S. Grigsby B. Aguero P. Eder E. Srour Isolation of primitive human bone marrow hematopoietic progenitor cells using hoechst 33342 and rhodamine 123 Exp. Hematology 1996 24 1215 1224 1:CAS:528:DyaK28XlvVaisLk%3D
30. C. Baum I. Weissman A. Tsukamoto A. Buckle B. Peault Isolation of a candidate human hematopoietic stem-cell population Proc. Nat. Acad. Sci. U.S.A. 1992 89 2804 2808 10.1073/pnas.89.7.2804 1:STN:280:DyaK383ht12iug%3D%3D
31. N. Uchida J. Combs S. Chen E. Zanjani R. Hoffman A. Tsukamoto Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities Blood 1996 88 1297 1305 8695847 1:CAS:528:DyaK28XkvF2js74%3D
32. W. Fleming E. Alpern N. Uchida K. Ikuta G. Spangrude I. Weissman Functional-heterogeneity is associated with the cell-cycle status of murine hematopoietic stem-cells J. Cell Biol. 1993 122 897 902 10.1083/jcb.122.4.897 1:STN:280:DyaK3szlt1OjsA%3D%3D 8349737
33. N. Uchida D. He A. Friera et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood Blood 1997 89 465 472 9002948 1:CAS:528:DyaK2sXlt1Shuw%3D%3D
34. A. Gothot R. Pyatt J. Mcmahel S. Rice E. Srour Functional heterogeneity of human CD34(+) cells isolated in Subcompartments of the G(0)/G(1) phase of the cell cycle Blood 1997 90 4384 4393 9373249 1:CAS:528:DyaK2sXnslWmu7Y%3D
35. R. Ploemacher N. Brons Cells with marrow and spleen repopulating ability and forming spleen colonies on day-16, day-12, and day-8 are sequentially ordered on the basis of increasing rhodamine-123 retention J. Cell. Phys. 1988 136 531 536 10.1002/jcp.1041360320 1:CAS:528:DyaL1cXmtVOkt7k%3D
36. M. Kim D. Cooper S. Hayes G. Spangrude Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activa-tion rather than dye efflux Blood 1998 91 4106 4117 9596656 1:CAS:528:DyaK1cXjsV2isbw%3D
37. N. Wolf A. Kone G. Priestley S. Bartelmez In vivo and in vitro characterization of long-term repopulating primitive hematopoietic-cells isolated by sequential Hoechst-33342-rhodamine-123 FACS selection Exp. Hematology 1993 21 614 622 1:CAS:528:DyaK2cXitl2msbc%3D
38. A. Strife B. Clarkson Biology of chronic myelogenous leukemia—is discordant maturation the primary defect? Sem. Hematology 1988 25 1 19 1:STN:280:DyaL1c7lvFansQ%3D%3D
39. B. Clarkson A. Strife A. Perez C. Lambek D. Wisniewski Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML) Leukemia & Lymphoma 1993 11 81 100 10.3109/10428199309064267
40. K. Shuai J. Halpern J. Tenhoeve X. Rao C. Sawyers Constitutive activation of STAT 5 by the Bcr-Abl oncogene in chronic myelogenous leukemia Oncogene 1996 13 247 254 8710363 1:STN:280:DyaK28zhtlamuw%3D%3D
41. Y.H. Jiang C.M. Verfaillie Inactivation of the cyclin-dependent kinase inhibitor P27 is responsible for overriding integrin engagement mediated inhibition of CML CD34(+) cells Blood 1999 94 435
42. A. Wilks A. Harpur Cytokine signal-transduction and the Jak family of protein-tyrosine kinases Bioessays 1994 16 313 320 10.1002/bies.950160505 1:CAS:528:DyaK2cXlsFCrtLg%3D 8024540
43. G. Wark C. Heyworth E. Spooncer et al. Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 α Oncogene 1998 16 1319 1324 10.1038/sj.onc.1201914 1:CAS:528:DyaK1cXit1KltL0%3D 9546433
44. C. Traycoff B. Halstead S. Rice J. Mcmahel E. Srour K. Cornetta Chronic myelogenous leukaemia CD34(+) cells exit G(0)G(1) phases of cell cycle more rapidly than normal marrow CD34(+) cells Brit. J. Haemat. 1998 102 759 767 10.1046/j.1365-2141.1998.00839.x 1:CAS:528:DyaK1cXlsleqtb0%3D 9722304
45. N. Uchida A. Friera D. He M. Reitsma A. Tsukamoto I. Weissman Hydroxyurea can be used to increase mouse C-Kit(+)Thy-1.1(Lo)Lin(-/Lo)Sca-1(+) hematopoietic cell number and frequency in cell cycle in vivo Blood 1997 90 4354 4357 9373246 1:CAS:528:DyaK2sXnslWmu7s%3D
46. C. Eaves J. Cashman A. Eaves Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia Leuk. Res. 1998 22 1085 1096 10.1016/S0145-2126(98)00113-1 1:STN:280:DyaK1M7hvFWjuw%3D%3D 9922073
47. C. Udomsakdi C. Eaves B. Swolin D. Reid M. Barnett A. Eaves Rapid decline of chronic myeloid leukemic-cells in long-term culture due to a defect at the leukemic stem-cell level Proc. Nat. Acad. Sci. U.S.A. 1992 89 6192 6196 10.1073/pnas.89.13.6192 1:STN:280:DyaK38zjsFaltg%3D%3D
48. A.C. Eaves M.J. Barnett L. Ponchio J.D. Cashman A. Petzer C.J. Eaves Differences between normal and CML stem cells: potential targets for clinical exploitation Stem Cells 1998 16 77 82 10.1002/stem.5530160809 11012149
49. C.J. Eaves A.C. Eaves K. Hinton Cell culture studies in CML Balliere’s Clinical Haematology 1987 London Balliere Tindall Saunders 931 945
50. T. Holyoake X. Jiang C. Eaves A. Eaves Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia Blood 1999 94 2056 206 10477735 1:CAS:528:DyaK1MXlvFCmsrg%3D